Additionally, the authors showed that CD44 expression was higher in patients with advanced diseases represented by lymph node involvement (N1) compared to that in individuals without lymph node metastases (N0). The gene discussed is CD44; the disease is metastatic malignant neoplasm in the lymph nodes.